...
首页> 外文期刊>Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine >Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy.
【24h】

Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy.

机译:188 188标记的白蛋白微球B 20的制备和生物分布:一种有前途的放射治疗新剂。

获取原文
获取原文并翻译 | 示例

摘要

Intra-arterial infusion of labeled particles is an effective method for endoradiotherapy of tumors. In this study, we radiolabeled biodegradable HSA microspheres (mean diameter = 25 microm) with the short-lived beta-emitter 188Re available from the aluminia-based 188W/188Re generator system. After 1 h 35-40% of the relative large amount of Sn(II) chloride required for effective reduction of Re(VII) for efficient attachment to the particles is precipitated as an amorphous coat of tin hydroxid colloid on the particle surface. The final 188Re bound to the particles was found to be stable in vitro. The radiolabelling yield was > 90%. The biological half-life was > 250 h and demonstrated sufficient in vivo stability after i.v. injection in Wistar rats. Because of the attractive properties of 188Re and the uniform particle size and stability, in vivo, this new agent is an attractive candidate for endoradiotherapy of tumors after selective catheterization.
机译:动脉内灌注标记颗粒是进行肿瘤内放射治疗的有效方法。在这项研究中,我们用基于铝的188W / 188Re发生器系统的短寿命β-发射体188Re放射性标记了可生物降解的HSA微球(平均直径= 25微米)。 1小时后,为了有效地附着到颗粒上而有效还原Re(VII)所需的相对大量的氯化锡(II)的35-40%作为氢氧化锡胶体的无定形涂层沉淀在颗粒表面上。发现与颗粒结合的最终188Re在体外是稳定的。放射性标记产率> 90%。生物学半衰期> 250小时,并在静脉内注射后表现出足够的体内稳定性。 Wistar大鼠注射。由于188Re具有吸引人的特性,并且在体内具有均一的粒径和稳定性,因此该新药是选择性导管插入后进行肿瘤内放射治疗的诱人候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号